Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults

This was a randomized, placebo-controlled, Phase I/II study conducted in a Japanese cohort to assess the safety and immunogenicity of Clostridium difficile vaccine (the same formulation as that used in the ongoing global Phase III study). Healthy Japanese adults aged 40–75 years were randomized to r...

Full description

Bibliographic Details
Main Authors: Osamu Matsuoka, Dhaval M. Patel, Shin Sasaki, Hayato Oka, Toru Sasaki, Patricia J. Pietrobon, Thelma Laot, Alain Bouckenooghe, Josemund Menezes, Guy de Bruyn
Format: Article
Language:English
Published: Taylor & Francis Group 2018-02-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
clostridium difficile
immunogenicity
safety
vaccine
Online Access:http://dx.doi.org/10.1080/21645515.2017.1395538

Internet

http://dx.doi.org/10.1080/21645515.2017.1395538

Similar Items